These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 22694006)

  • 1. Genetic profiling in acute myeloid leukemia.
    Horne G; Brewin J; Chevassut T
    N Engl J Med; 2012 Jun; 366(24):2321; author reply 2321-2. PubMed ID: 22694006
    [No Abstract]   [Full Text] [Related]  

  • 2. Profiles in leukemia.
    Godley LA
    N Engl J Med; 2012 Mar; 366(12):1152-3. PubMed ID: 22417205
    [No Abstract]   [Full Text] [Related]  

  • 3. [Acute myeloid leukemia: from risk-adapted to genotype-specific therapy].
    Kayser S; Schlenk RF
    Dtsch Med Wochenschr; 2011 Aug; 136(31-32):1577-80. PubMed ID: 21809245
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnosis and Therapy of Acute Myeloid Leukemia in the Era of Molecular Risk Stratification.
    Komanduri KV; Levine RL
    Annu Rev Med; 2016; 67():59-72. PubMed ID: 26473413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
    Nardi V; Hasserjian RP
    Surg Pathol Clin; 2016 Mar; 9(1):143-63. PubMed ID: 26940274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-Generation Sequencing and Detection of Minimal Residual Disease in Acute Myeloid Leukemia: Ready for Clinical Practice?
    Pastore F; Levine RL
    JAMA; 2015 Aug; 314(8):778-80. PubMed ID: 26305647
    [No Abstract]   [Full Text] [Related]  

  • 7. Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling.
    Wang M; Lindberg J; Klevebring D; Nilsson C; Mer AS; Rantalainen M; Lehmann S; Grönberg H
    Leukemia; 2017 Oct; 31(10):2029-2036. PubMed ID: 28167833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex high-throughput gene mutation analysis in acute myeloid leukemia.
    Dunlap J; Beadling C; Warrick A; Neff T; Fleming WH; Loriaux M; Heinrich MC; Kovacsovics T; Kelemen K; Leeborg N; Gatter K; Braziel RM; Press R; Corless CL; Fan G
    Hum Pathol; 2012 Dec; 43(12):2167-76. PubMed ID: 22658276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haematological cancer: Improving prediction of relapse risk.
    Romero D
    Nat Rev Clin Oncol; 2015 Oct; 12(10):564. PubMed ID: 26346846
    [No Abstract]   [Full Text] [Related]  

  • 10. High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.
    Willemze R; Suciu S; Meloni G; Labar B; Marie JP; Halkes CJ; Muus P; Mistrik M; Amadori S; Specchia G; Fabbiano F; Nobile F; Sborgia M; Camera A; Selleslag DL; Lefrère F; Magro D; Sica S; Cantore N; Beksac M; Berneman Z; Thomas X; Melillo L; Guimaraes JE; Leoni P; Luppi M; Mitra ME; Bron D; Fillet G; Marijt EW; Venditti A; Hagemeijer A; Mancini M; Jansen J; Cilloni D; Meert L; Fazi P; Vignetti M; Trisolini SM; Mandelli F; de Witte T
    J Clin Oncol; 2014 Jan; 32(3):219-28. PubMed ID: 24297940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomes.
    Ley TJ; Minx PJ; Walter MJ; Ries RE; Sun H; McLellan M; DiPersio JF; Link DC; Tomasson MH; Graubert TA; McLeod H; Khoury H; Watson M; Shannon W; Trinkaus K; Heath S; Vardiman JW; Caligiuri MA; Bloomfield CD; Milbrandt JD; Mardis ER; Wilson RK
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14275-80. PubMed ID: 14614138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current therapy for acute myeloid leukemia and acute promyelocytic leukemia].
    Miyawaki S
    Rinsho Ketsueki; 2014 Jan; 55(1):31-41. PubMed ID: 24492035
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of adult patients with acute myeloid leukemia (excluding acute promyelocytic leukemia)].
    Usui N
    Rinsho Ketsueki; 2014 Oct; 55(10):1808-16. PubMed ID: 25297744
    [No Abstract]   [Full Text] [Related]  

  • 14. Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group.
    Krönke J; Schlenk RF; Jensen KO; Tschürtz F; Corbacioglu A; Gaidzik VI; Paschka P; Onken S; Eiwen K; Habdank M; Späth D; Lübbert M; Wattad M; Kindler T; Salih HR; Held G; Nachbaur D; von Lilienfeld-Toal M; Germing U; Haase D; Mergenthaler HG; Krauter J; Ganser A; Göhring G; Schlegelberger B; Döhner H; Döhner K
    J Clin Oncol; 2011 Jul; 29(19):2709-16. PubMed ID: 21555683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis of MYH11 in acute myeloid leukemia.
    Sammalkorpi H; Alhopuro P; Niittymäki I; Orntoft TF; Hokland P; Karhu A; Aaltonen LA
    Leuk Lymphoma; 2008 Sep; 49(9):1829-31. PubMed ID: 18798114
    [No Abstract]   [Full Text] [Related]  

  • 16. The importance of plasma D-2HG measurement in screening for IDH mutations in acute myeloid leukaemia.
    McGehee E; Rakheja D; Oliver D; Chen W; Boriack R; Collins RH
    Br J Haematol; 2016 Apr; 173(2):323-6. PubMed ID: 26195003
    [No Abstract]   [Full Text] [Related]  

  • 17. Leukemic stem cell gene expression signature and clinical outcomes in acute myeloid leukemia.
    Masuda S
    JAMA; 2011 Mar; 305(11):1094; author reply 1094-5. PubMed ID: 21406645
    [No Abstract]   [Full Text] [Related]  

  • 18. Whole-genome-amplified DNA as a source for mutational analysis underestimates the frequency of mutations in pediatric acute myeloid leukemia.
    Rosenquist R; Ehrencrona H; Hasle H; Palle J; Kanduri M
    Leukemia; 2013 Feb; 27(2):510-2. PubMed ID: 22996295
    [No Abstract]   [Full Text] [Related]  

  • 19. DNMT3A Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous Leukemia.
    Sehgal AR; Gimotty PA; Zhao J; Hsu JM; Daber R; Morrissette JD; Luger S; Loren AW; Carroll M
    Clin Cancer Res; 2015 Apr; 21(7):1614-20. PubMed ID: 25609058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel point mutation within the juxtamembrane domain of the flt3 gene in acute myeloid leukemia.
    Gianfelici V; Diverio D; Breccia M; Buffolino S; Derme V; Di Lascio A; Marinelli M; Santangelo S; Meloni G; Foà R
    Ann Hematol; 2011 Jul; 90(7):845-6. PubMed ID: 20924583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.